Related Experiment Video
Updated: Aug 6, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
A knowledge-enhanced domain-aware large language model agent for atrial fibrillation management
Yijun Wang1,2, Chen Peng3, Ruijie Hu3
1Department of Cardiology; The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China.
Abstract:
Large language models (LLMs) show considerable potential for atrial fibrillation (AF) management, yet current clinical applications frequently remain suboptimal due to accuracy limitations. To address these limitations, this study developed PULSE (Potentiated User-friendly LLM-driven Search Engine), a novel knowledge-enhanced, domain-aware LLM agent specifically designed to improve AF patient self-management across the entire care continuum. The proposed framework integrates multimodal inputs, meticulously curated clinical knowledge bases, optimized prompt engineering, and retrieval-augmented generation within an agent-based architecture. Performance was rigorously evaluated against four leading base LLMs using response quality (clinical accuracy, content integrity, practical utility, and patient safety) and readability (clarity, conciseness, and empathy). Comprehensive clinical validation was subsequently conducted through blinded expert assessment of 75 real-world AF-related patient queries. The results demonstrated that PULSE improved clinical accuracy, content integrity, utility, and safety (P < 0.05) across all tested models. Furthermore, it substantially enhanced empathy and clarity while maintaining comparable conciseness. Overall, PULSE improves both the factual accuracy and readability of patient-facing medical outputs, highlighting the immense clinical potential of agent-driven LLM systems to advance chronic disease self-management and improve long-term patient outcomes.
More Related Videos
Related Concept Videos
Atherosclerosis III: Management
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Dysrhythmias VI: Management of Dysrhythmias
Heart Failure V: Medical Management
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
